Evidence map›Paper›PMID 20300112›Full record

ArticleCell death and differentiation2010

CAML regulates Bim-dependent thymocyte death.

C E Edgar, L D Lindquist, D L McKean, A Strasser, R J Bram

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

C E EdgarDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.
L D Lindquist
D L McKean
A Strasser
R J Bram
Mayo Clinic · USWalter and Eliza Hall Institute of Medical Research · AU

Funding

PHD TRAINING PROGRAM IN BASIC IMMUNOLOGYT32AI007425 · NIAID · MAYO CLINIC ROCHESTER · PI SHAPIRO, VIRGINIA SMITH · 1995 to 2020
$3.6M
CAML in T cell Development and FunctionR01AI074320 · NIAID · MAYO CLINIC ROCHESTER · PI BRAM, RICHARD J · 2008 to 2011
$1.4M
CAML in T cell Development and FunctionR56AI074320 · NIAID · MAYO CLINIC ROCHESTER · PI BRAM, RICHARD J · 2007 to 2007
$340k
NIAID NIH HHS 2R01AI074320NIAID NIH HHS R01 AI074320NIAID NIH HHS R56 AI074320NIAID NIH HHS T32 AI007425NIAID NIH HHS T32 AI07425-14
6 · The paper itself

Abstract

Appropriate control of apoptosis during T lymphocyte differentiation is critical for destruction of T cells bearing potentially autoreactive or useless immuno-receptors and for survival of those T cells bearing antigen receptors that may recognize foreign proteins. Despite the well-established importance of thymocyte survival, the exact signals regulating thymocyte apoptosis have not been fully elucidated. Here, we show that thymocytes lacking the endoplasmic reticulum protein calcium-modulating cyclophilin ligand (CAML) failed to undergo normal T-cell development and exhibited dramatically increased rates of apoptosis. In vitro, CAML-deficient thymocytes accumulated high levels of reactive oxygen species (ROS) and underwent abnormally accelerated death in response to several cytotoxic stimuli, including treatment with etoposide, cytokine deprivation, or Fas ligation. Although neither p53 deletion nor loss of Fas rescued the survival and continued development of CAML-deficient thymocytes, removal of the pro-apoptotic BH3-only Bcl-2 family member Bim significantly restored their survival. This work reveals CAML to be a critically important regulator of ROS- and Bim-dependent thymocyte death.

Indexed as

ApoptosisAdaptor Proteins, Signal TransducingAnimalsApoptosis Regulatory ProteinsBcl-2-Like Protein 11Etoposidefas ReceptorMembrane ProteinsMiceProto-Oncogene ProteinsReactive Oxygen SpeciesT-LymphocytesTumor Suppressor Protein p53Adaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsBcl2l11 protein, mouseBcl-2-Like Protein 11Caml protein, mouseEtoposideFas protein, mousefas ReceptorMembrane ProteinsProto-Oncogene ProteinsReactive Oxygen SpeciesTumor Suppressor Protein p53

Identifiers

PMID20300112
PMCPMC2890044
OpenAlexW1976701484

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.